ConductScience.org, home
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
API referenceFor AI assistants

Trial · NCT01628965

Results by group21

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 21

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Any AEs140participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Treatment-related AEs122participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962SAEs18participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Severe AEs9participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Discontinuation due to AEs30participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Severe laboratory abnormality14participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962≥30 mmHg decrease*1participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Treatment-related AE of orthostatic hypotension2participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962QTcB ≥500 ms1participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Weight decrease of 5% or more53participants
Incidence and Severity of Adverse Events, Vital Signs, and Laboratory ParametersSPM 962Weight increase of 5% or more22participants
Total of Unified Parkinson's Disease Rating Scale (UPDRS) Part 2 Sum Score and Part 3 Sum ScoreSPM 962Week 12-9.9Standard Deviation 8.7Scores on a scale
Total of Unified Parkinson's Disease Rating Scale (UPDRS) Part 2 Sum Score and Part 3 Sum ScoreSPM 962Week 24-8.3Standard Deviation 9.5Scores on a scale
Total of Unified Parkinson's Disease Rating Scale (UPDRS) Part 2 Sum Score and Part 3 Sum ScoreSPM 962Week 52-6.5Standard Deviation 10.1Scores on a scale
Skin Irritation Score of the Application SiteSPM 962-20participants
Skin Irritation Score of the Application SiteSPM 962±57participants
Skin Irritation Score of the Application SiteSPM 962+46participants
Skin Irritation Score of the Application SiteSPM 962++12participants
Skin Irritation Score of the Application SiteSPM 962+++6participants
Skin Irritation Score of the Application SiteSPM 962++++1participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01628965/results

API referenceFor AI assistants